Trulieve Cannabis Corp. Subordinate Voting Shares (TRLV)
NYSE: TRLVHealth Care Medicinal Chemicals and Botanical Products USD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
TRLV stock chart
Technical analysisKey statistics
All statistics- Market cap
- $1.48B
- Forward P/E
- 29.29
- EPS (TTM)
- -$2.31
- Dividend yield
- None
- 52-week range
- 5.00 – 13.28
- Day range
- 8.68 – 9.42
- Volume / Avg
- 1.71M / 1.85M
- Beta
- —
- Shares outstanding
- 170.41M
52-week range
TRLV stock today
Shares of Trulieve Cannabis Subordinate Voting Shares (TRLV) finished lower on Nov 20 at $8.68, a drop of 7.17% or $0.67 per share, versus the S&P 500's 3.70% decline. At this level, TRLV sits in the middle of its 52-week range of $5.00 to $13.28: 34.6% below the high, set on Jun 9, 2026 and 73.6% above the low. TRLV is down 0.1% year to date, underperforming the S&P 500 (+1.2%). Over the past 12 months, the stock has gained 61.3%.
Trulieve Cannabis Subordinate Voting Shares has posted a net loss over the last twelve months (EPS of -$2.31), so its P/E ratio is not meaningful.
Summary generated from market data by MetaCap's automated system. Methodology
About Trulieve Cannabis Subordinate Voting Shares
Company profileTrulieve Cannabis Corp. operates as a cannabis retailer in the United States. The company cultivates, processes, and manufactures cannabis products and distributes its products to its dispensaries, as well as through home delivery.
- Sector
- Health Care
- Industry
- Medicinal Chemicals and Botanical Products
- CEO
- Ms. Kimberly Rivers J.D.
- Headquarters
- Tallahassee, FL
- Employees
- 5,000
- Website
- trulieve.com
Financial highlights
Full financialsIn fiscal 2025, Trulieve Cannabis Subordinate Voting Shares generated $1.18 billion in revenue, down 0.4% from fiscal 2024, its first annual decline since 2023. Trulieve Cannabis Subordinate Voting Shares reported a net loss of $122.2 million, compared with a loss of $160.6 million a year earlier. Gross margin was 60.2% (down from 60.3%) and operating margin 12.1%.
| Fiscal year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Revenue | $1.18B | $1.19B | $1.13B | $1.22B | $931.93M |
| Growth | -0.45% | +5.07% | -7.31% | +30.72% | +78.69% |
| Net income | $-122.25M | $-160.58M | $-533.14M | $-252.73M | $17.45M |
| EPS (diluted) | $-0.58 | $-0.79 | $-2.28 | $-0.95 | $0.21 |
Analyst forecast
ForecastConsensus (7 analysts)
strong_buy
Avg. price target
$18.32+111.06%
- Strong buy 1
- Buy 6
- Hold 0
- Sell 0
- Strong sell 0
Target range
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
Earnings
Earnings history- Last reported (Sep/2026)
- Nov 5, 2026
- EPS actual vs est.
- $0.00 vs $0.09
- Surprise
- -100.00%
TRLV news
All TRLV news- Trulieve Was the First U.S. Pure-Play Cannabis Stock on the NYSE. Here's Which Stock Could Be Next.Nasdaq
- Trulieve to Open Medical Cannabis Dispensary in Tampa, FloridaPR Newswire
- Trulieve (TRLV) Q3 2026 Earnings Call TranscriptNasdaq
- Trulieve Receives DEA Registrations for State-Licensed Medical Marijuana OperationsPR Newswire
- After Hours Most Active for Jun 12, 2026 : SPCX, IONQ, NVDA, CPNG, AVGO, TME, INTC, TRLV, SOMN, F, AUR, NFLXNasdaqIONQ, NVDA, CPNG, AVGO
Trulieve Cannabis Subordinate Voting Shares peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| CRONCronos Group Inc. | 3.04 | -1.30% | $1.11B | vs TRLV |
| RGCRegencell Bioscience Holdings Limited | 4.18 | -4.13% | $2.07B | vs TRLV |
| OBIOOrchestra BioMed Holdings Inc. | 6.58 | -6.00% | $517.88M | vs TRLV |
| SNDLSNDL Inc. | 1.17 | -5.65% | $285.20M | vs TRLV |
| TLRYTilray Brands Inc. | 1.89 | -8.70% | $279.32M | vs TRLV |
| ACBAurora Cannabis Inc. | 4.16 | -2.35% | $273.50M | vs TRLV |
| USNAUSANA Health Sciences Inc. | 12.94 | -1.67% | $239.24M | vs TRLV |
| MDWDMediWound Ltd. | 13.59 | +0.37% | $195.56M | vs TRLV |
Indexes, lists and sector
Trulieve Cannabis Subordinate Voting Shares stock FAQ
What is Trulieve Cannabis Subordinate Voting Shares's stock price today?
TRLV last traded at $8.68 as of Nov 20, 4:00 PM EST, down 7.17% on the day. Prices are delayed at least 15 minutes.
Who is Trulieve Cannabis Subordinate Voting Shares's CEO?
Ms. Kimberly Rivers J.D. is the chief executive officer of Trulieve Cannabis Corp. Subordinate Voting Shares, which has about 5,000 employees.
What is the TRLV 52-week high?
The 52-week high for TRLV is $13.28 and the 52-week low is $5.00. The stock is currently 34.6% below its high.